Results 51 to 60 of about 934,412 (371)
Characterization of pulmonary vein reconnection post Cryoballoon ablation
Indian Pacing and Electrophysiology Journal, 2019 Background: The Arctic Front Cryoballoon System is a technology in which substrate alterations in patients with atrial fibrillation (AF) recurrence have not been well characterized.
Shivang Shah +5 more
doaj +1 more source
Novel concepts in atrial fibrillation ablation—breaking the trade‐off between efficacy and safety
Journal of Arrhythmia, 2021 Despite substantial technological and procedural advances that have improved the efficacy and safety of AF ablation in recent years, the long‐term durability of ablation lesions is still not satisfactory.
Till F. Althoff, Lluís Mont
doaj +1 more source
Edoxaban versus warfarin in patients with atrial fibrillation.
New England Journal of Medicine, 2013 BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
R. Giugliano +20 more
semanticscholar +1 more source
Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]
, 2017 Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core +1 more source
The 4q25 variant rs13143308T links risk of atrial fibrillation to defective calcium homoeostasis [PDF]
, 2019 Aims: Single nucleotide polymorphisms on chromosome 4q25 have been associated with risk of atrial fibrillation (AF) but the exiguous knowledge of the mechanistic links between these risk variants and underlying electrophysiological alterations hampers ...
Benítez Iglesias, Raúl +9 more
core +2 more sources
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure
Circulation, 2021 Supplemental Digital Content is available in the text. Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials have reported improved outcomes, including freedom from AF recurrence, quality of life, and survival ...
D. Packer +9 more
semanticscholar +1 more source
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
International Journal of Molecular Sciences, 2021 Atrial fibrillation (AF) is the most frequent arrhythmia managed in clinical practice, and it is linked to an increased risk of death, stroke, and peripheral embolism.
M. Sagris +5 more
semanticscholar +1 more source
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range [PDF]
, 2016 BACKGROUND: The benefits and harms of oral anticoagulation (OAC) therapy in patients with only one stroke risk factor (i.e. CHA2DS2-VASc= 1 in males, or 2 in females) has been subject of debate.
Lip, Gregory Y. H., Proietti, Marco
core +2 more sources
Canadian Medical Association Journal, 2004 Atrial fibrillation (AF) is the most common sustained dysrhythmia in adults. It is ironic, then, that although mechanisms and effective treatments for most other supraventricular tachyarrhythmias have been discovered, AF remains incompletely understood and poorly treated.
George D, Veenhuyzen +2 more
openaire +2 more sources
Nature Reviews Cardiology, 2022 Inflammation has been implicated in atrial fibrillation (AF), a very common and clinically significant cardiac rhythm disturbance, but its precise role remains poorly understood.
D. Dobrev +4 more
semanticscholar +1 more source